Washington, D.C. decriminalizes psychedelic plants
Voters in Washington, D.C. overwhelmingly approved Initiative 81, decriminalizing psychedelic plants. The measure does not legalize psychedelic plants and mushrooms, but recategorizes them «as the lowest priority of law enforcement by police», according to the initiative's wording.
The Initiative has been approved at 76%. It concerns plants containing :
- Ibogaine (Ayahuasca)
- Dimethyltryptamine
- Mescaline
- Psilocybin
- Psilocyne
The District of Columbia follows Denver, Colorado, Oakland and Santa Cruz (California) and Ann Arbor (Michigan) in the decriminalization of certain psychedelics.
Denver passed its initiative in May, while Oakland and Santa Cruz legislators passed their resolutions in June and February, respectively. The city council of Ann Arbor, Michigan, passed its measure in September.
None of these measures decriminalizing psychedelic plants include synthetic products such as LSD or MDMA.
Voters of the’Oregon legalized medical psilocybin in last night's general election and passed another measure decriminalizing all drugs.
The Washington initiative was started by Melissa Lavasani, a city government employee who used microdoses of psilocybin to help her recover from post-partum depression.
«Everyone knows, at least in the campaign, that I was hoping for 70% [of votes in favor]. [...] We've changed the game here. We've turned this dialogue into something people can feel, touch, see and hear. We're trying to normalize mental health, we're trying to normalize psychedelics, we're trying to normalize connecting with your community. The psychedelic movement was born on the West Coast, but DC tonight [voted] and showed that psychedelics play a major role in how we can heal as a community, how we can heal as a city and how we can heal as a country.» said Melissa Lavasani, on Facebook
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login